TRH THYROTROPIN 50 MG

TRH Thyrotropin 50 mg – High-Dose Thyroid Peptide for Research | Peptide Hubs

TRH Thyrotropin (Thyrotropin-Releasing Hormone) is a tripeptide hormone produced by the hypothalamus that plays a critical role in regulating thyroid function through pituitary stimulation. This 50 mg (2 mL) high-dosage vial by Peptide Hubs is designed for research applications involving prolonged or high-output stimulation of the HPT (hypothalamic-pituitary-thyroid) axis, as well as neuroendocrine and metabolic studies.

What Is TRH Thyrotropin?

TRH stimulates the anterior pituitary to release thyroid-stimulating hormone (TSH), which in turn promotes the production of T3 and T4 by the thyroid gland. While its primary role is endocrine regulation, TRH is also being studied for its effects on the central nervous system, neuroprotection, and autonomic regulation. According to published literature, TRH exhibits antidepressant-like and anti-fatigue effects in lab models, making it a peptide of growing interest beyond endocrinology.

Research Applications

• Stimulation of thyroid hormones (TSH, T3, T4)
• Neuroendocrine feedback modulation
• Metabolism and body temperature regulation
• CNS neuropeptide activity and antidepressant models
• Recovery protocols involving thyroid axis normalization

Recommended Dosage Protocol

In research, TRH Thyrotropin is typically administered at 5–15 mg per week in divided doses. This 50 mg format allows flexibility for longer studies or multi-subject protocols. Injections are usually subcutaneous or intramuscular, depending on research design. TRH has a short active life and may require multiple administrations per week in some models.

Peptides Often Stacked with TRH Thyrotropin

To maximize endocrine or neurostimulatory outcomes, researchers often combine TRH with other synergistic peptides:

• CJC-1295 DAC – supports GH axis and extended pituitary stimulation
• Ipamorelin – enhances growth hormone release without cortisol elevation
• Selank – for anxiolytic and neuroimmune balance
• Thymalin – assists with immune and endocrine gland balance
• GHK-Cu – supports systemic repair and hormone receptor sensitivity

Safety Profile in Research Models

TRH Thyrotropin is considered well-tolerated in preclinical studies. It does not interact with steroid hormone pathways and has no reported hepatotoxicity or cardiovascular risks. It is rapidly metabolized and may cause transient flushing or injection site sensitivity. It is not intended for human consumption or therapeutic use—research only.

USA Shipping and Peptide Hubs Assurance

Peptide Hubs provides fast and reliable USA domestic shipping for all research peptides, including high-dose TRH Thyrotropin 50 mg. Every vial is manufactured in GMP-certified laboratories and tested for purity and sterility. For comprehensive metabolic or thyroid studies, researchers may consider adding AOD 9604 or BPC-157 for additional hormonal and regenerative insight.

Frequently Asked Questions